| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/07/2004 | US20040197273 Suspension aerosol formulations |
| 10/07/2004 | US20040197262 Micronized barium sulfate |
| 10/07/2004 | US20040195710 Generating biocompatible microspheres; obtain macromolecule solution, mix biocompatible particles, form geometric shapes, expose shape to radiation, recover microspheres |
| 10/07/2004 | US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof |
| 10/07/2004 | US20040194338 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 10/07/2004 | DE4035253B4 Injektionslösungen und Verfahren zu deren Herstellung Injection solutions and processes for their preparation |
| 10/07/2004 | DE10314377A1 Pharmaceutical composition useful for tumor therapy comprises water, oxaliplatin and an acid other than oxalic acid |
| 10/07/2004 | DE10064870B4 Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen Sulfur-containing amphiphiles for the transfer of biologically active molecules into cells |
| 10/07/2004 | DE10005936B4 Creme zur äußeren Anwendung auf der Nasenhaut Cream for topical application to the skin of the nose |
| 10/07/2004 | CA2530725A1 Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same |
| 10/07/2004 | CA2520257A1 Long acting biologically active conjugates |
| 10/07/2004 | CA2519707A1 Prostaglandin compositions for the treatment of erectile dysfunction |
| 10/07/2004 | CA2519705A1 Antifungal nail coat and method of use |
| 10/07/2004 | CA2519691A1 Angiogenesis promotion by prostaglandin compositions and methods |
| 10/07/2004 | CA2519488A1 Micro-cluster compositions |
| 10/07/2004 | CA2517828A1 Compositions and methods for treatment of premature ejaculation |
| 10/06/2004 | EP1464673A2 Polyanhydrides with biologically active degradation products |
| 10/06/2004 | EP1464341A1 Ubiquinone-containing water-soluble formulation for ophthalmic use |
| 10/06/2004 | EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation |
| 10/06/2004 | EP1464069A2 Probe for mass spectrometry |
| 10/06/2004 | EP1463842A1 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN KINASE C ALPHA (PKC-ALPHA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/06/2004 | EP1463732A1 Hydroxycucurbituril derivatives, their preparation methods and uses |
| 10/06/2004 | EP1463558A2 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| 10/06/2004 | EP1463539A1 Controlled release therapeutic wound dressings |
| 10/06/2004 | EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 10/06/2004 | EP1463518A2 Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
| 10/06/2004 | EP1463513A1 Stabilized brivudine topical formulations |
| 10/06/2004 | EP1463512A2 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| 10/06/2004 | EP1463492A1 Adhesive and binding agent for dermal or transdermal treatment systems |
| 10/06/2004 | EP1463491A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 10/06/2004 | EP1463490A1 Glucan based film delivery systems |
| 10/06/2004 | EP1463489A1 Composite dosage forms |
| 10/06/2004 | EP1463488A1 Pharmaceutical composition comprising skimmed milk powder |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1463486A2 Anaesthetic compositions and method for their administration |
| 10/06/2004 | EP1463483A1 New composition |
| 10/06/2004 | EP1463440A2 Prevention of flap necrosis in plastic surgery |
| 10/06/2004 | EP1463438A2 Endomural therapy |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1390518B1 Buffer solution for electroporation and a method comprising the use of the same |
| 10/06/2004 | EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 10/06/2004 | EP1309309B1 Dermatological composition |
| 10/06/2004 | EP1286758B1 Emulsifiers |
| 10/06/2004 | EP1284785B1 Medicament-loaded transdermal reservoir and method for its formation |
| 10/06/2004 | EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent |
| 10/06/2004 | EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use |
| 10/06/2004 | EP1173147B1 Sunscreen agents containing hydroxycarboxylic acid alkyl,-and/or alkenyloligo- glycoside esters |
| 10/06/2004 | EP1150569A4 Method for reducing hip joint laxity |
| 10/06/2004 | EP1135163B1 Topical compositions comprising ascomycins |
| 10/06/2004 | EP1133284B1 A process for the preparation of crystalline particles |
| 10/06/2004 | EP1096954B1 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 10/06/2004 | EP1094797B1 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 10/06/2004 | EP1019096B1 Bioresorbable compositions for implantable prostheses |
| 10/06/2004 | EP0977588B1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 10/06/2004 | EP0975340B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 10/06/2004 | EP0869810B1 Cyclosporin-containing soft capsule preparations |
| 10/06/2004 | EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 10/06/2004 | CN1535268A Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 10/06/2004 | CN1535168A Controlled release composition and method of producing the same |
| 10/06/2004 | CN1535163A Delivery system for nucleic acids |
| 10/06/2004 | CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1535142A Transdermal patch for administering fentanyl |
| 10/06/2004 | CN1535140A Microparticle compositions and method for manufacture thereof |
| 10/06/2004 | CN1535138A Ophthalmic composition containing N-acetyl-cysteine for treatment of dry-eye syndrome |
| 10/06/2004 | CN1533808A Composition for treating coronavirus infection and SARS and method |
| 10/06/2004 | CN1169959C Polypeptide variants with raised heparin-binding capacity |
| 10/06/2004 | CN1169951C Modified arginine deiminase |
| 10/06/2004 | CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage |
| 10/06/2004 | CN1169525C Pharmaceutical formulations for taxanes |
| 10/06/2004 | CN1169522C Controlled release bead, of producing the same and multiple unit formulation comprising it |
| 10/06/2004 | CN1169520C Perforated microparticles and methods for use |
| 10/05/2004 | US6800728 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 10/05/2004 | US6800672 Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same |
| 10/05/2004 | US6800616 Administering a therapeutic agent that is cytotoxic or cytostatic with respect to cd4+ t cells, but has reduced cytotoxic or cytostatic activity with respect to t lymphocyte stem cells |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800609 Isolated peptide of the horny layer and user thereof |
| 10/05/2004 | US6800297 Porous COX-2 inhibitor matrices and methods of manufacture thereof |
| 10/05/2004 | US6800296 Modification of surfaces using biological recognition events |
| 10/05/2004 | US6800295 Water soluble sheet composition |
| 10/05/2004 | US6800294 Eucalyptus oil, cajeput oil, lemongrass oil, clove bud oil, peppermint oil, piperonyl and piperonyl butoxide; treating or preventing animal ectoparasitic infestation |
| 10/05/2004 | US6800293 Employing emulsifier comprised of hydroxycarboxylic acid alkyl and/or alkenyl oligoglycoside ester and fatty alcohol; heat and storage stability; improved thickening; lightweight feel |
| 10/05/2004 | US6800290 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 10/05/2004 | US6800278 High cationicity acrylate or acrylamide polymer; nonirrita-ting; absorbs exudates; enhances sterile environment; loose adhesion; no residue |
| 10/05/2004 | US6800276 For use in cosmetics, pharmaceuticals, textile, printing, paper, leather, adhesives and agrochemical industry |
| 10/05/2004 | CA2338707C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2338480C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2264243C Glp-1 derivatives |
| 10/05/2004 | CA2244698C Derivatives of camptothecin for use in treating cancer |
| 10/05/2004 | CA2154469C Structured copolymers and their uses as absorbents, gels and carriers of metal ions |
| 10/01/2004 | CA2425031A1 Pharmaceutical compositions |
| 09/30/2004 | WO2004083258A2 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | WO2004083255A1 Hymenaea seed polysaccharide |
| 09/30/2004 | WO2004083251A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | WO2004083234A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 09/30/2004 | WO2004083201A1 Pharmaceutical preparations containing arginine amides |
| 09/30/2004 | WO2004082720A1 Drug for treating hemophilia and method of treating hemophilia using the same |
| 09/30/2004 | WO2004082719A1 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 09/30/2004 | WO2004082718A1 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 09/30/2004 | WO2004082708A2 Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |